Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene

BACKGROUND: Mesenchymal-to-epithelial transition (MET) exon 14 skipping mutations and MET gene amplification occur in 3–5% of non-small cell lung cancer (NSCLC) patients. Tyrosine kinase inhibitors (TKIs) targeting MET alterations have shown promising results in these patients. OBJECTIVE: The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Alessa, Bankel, Lorenz, Hiltbrunner, Stefanie, Rechsteiner, Markus, Rüschoff, Jan H., Rushing, Elisabeth Jane, Britschgi, Christian, Curioni-Fontecedro, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684265/
https://www.ncbi.nlm.nih.gov/pubmed/36136211
http://dx.doi.org/10.1007/s11523-022-00918-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684265/
https://www.ncbi.nlm.nih.gov/pubmed/36136211
http://dx.doi.org/10.1007/s11523-022-00918-6

Ejemplares similares